Overview

This bill amends the Mesothelioma Act 2014 to add a research supplement to the existing levy on insurers. This supplement will fund research into mesothelioma, a cancer caused by asbestos exposure. The supplement is capped at 1% of the existing levy.

Description

The Mesothelioma (Amendment) Bill modifies the 2014 Mesothelioma Act. It introduces a "research supplement" to the levy imposed on insurers. This supplement, capped at 1% of the existing levy amount, will specifically fund mesothelioma research. Regulations will determine the exact percentage and how the funds are distributed via grants or other financial assistance for research. The Secretary of State must consult insurers, medical charities, research foundations, and other relevant stakeholders before setting the regulations for this research supplement. The scheme administrator will be responsible for allocating the funds, potentially using other bodies to handle applications.

Government Spending

The bill will not directly increase government spending. Instead, it will generate additional funding for mesothelioma research through a small percentage increase in the existing levy on insurers. The exact amount will depend on the levy amount and the percentage set for the research supplement, but it is capped at 1% of the current levy total. No specific figures are provided in the bill itself.

Groups Affected

• Insurers: Will experience a small increase (up to 1%) in their levy payments.
• Mesothelioma sufferers and their families: May indirectly benefit from the improved research funded by the supplement.
• Medical charities and research foundations: Could receive grants to fund mesothelioma research.
• Researchers: May receive funding for mesothelioma research projects.

Powered by nyModel